interestingly , all therapy responders showed a markedly depressed lymphocyte proliferative capability ( lpc , tested with tetanus toxoid/streptodornase as antigens ) compared to the non-responders before apheresis , with complete reversal to normal lpc during treatment .
C0087111
therapy
C0005791
apheresis